GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 22 filers reported holding GALMED PHARMACEUTICALS LTD in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $239,000 | -64.2% | 34,931 | -29.0% | 0.09% | -61.8% |
| Q3 2018 | $668,000 | +618.3% | 49,183 | +85.2% | 0.23% | +2812.5% |
| Q4 2016 | $93,000 | +43.1% | 26,556 | +80.6% | 0.01% | +33.3% |
| Q3 2016 | $65,000 | -19.8% | 14,707 | -19.0% | 0.01% | -45.5% |
| Q2 2016 | $81,000 | -5.8% | 18,148 | +4.6% | 0.01% | -8.3% |
| Q1 2016 | $86,000 | -33.3% | 17,348 | +2.4% | 0.01% | -25.0% |
| Q4 2015 | $129,000 | +10.3% | 16,948 | +7.3% | 0.02% | -11.1% |
| Q3 2015 | $117,000 | -19.3% | 15,788 | +9.5% | 0.02% | -25.0% |
| Q2 2015 | $145,000 | +11.5% | 14,416 | +4.3% | 0.02% | +41.2% |
| Q1 2015 | $130,000 | – | 13,816 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ibex Investors LLC | 418,000 | $5,676,000 | 3.15% |
| Knoll Capital Management, LLC | 210,000 | $2,881,000 | 2.44% |
| BVF INC/IL | 1,761,567 | $23,922,000 | 2.10% |
| P.A.W. CAPITAL CORP | 90,000 | $1,222,000 | 1.30% |
| 683 Capital Management, LLC | 1,350,000 | $18,333,000 | 1.19% |
| Vivo Capital, LLC | 851,492 | $11,563,000 | 1.16% |
| MEITAV INVESTMENT HOUSE LTD | 653,957 | $8,946,000 | 0.44% |
| Trellus Management Company, LLC | 16,711 | $227,000 | 0.33% |
| Nantahala Capital Management | 838,674 | $11,389,000 | 0.31% |
| MENTA CAPITAL LLC | 49,183 | $668,000 | 0.23% |